Literature DB >> 21953369

Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests.

Vicente Felipo1, Juan F Ordoño, Amparo Urios, Nisrin El Mlili, Carla Giménez-Garzó, Carolina Aguado, Olga González-Lopez, Remedios Giner-Duran, Miguel A Serra, Abdallah Wassel, Jose M Rodrigo, José Salazar, Carmina Montoliu.   

Abstract

UNLABELLED: Attention deficit is an early event in the cognitive impairment of patients with minimal hepatic encephalopathy (MHE). The underlying mechanisms remain unclear. Mismatch negativity (MMN) is an auditory event-related potential that reflects an attentional trigger. Patients with schizophrenia show impaired attention and cognitive function, which are reflected in altered MMN. We hypothesized that patients with MHE, similarly to those with schizophrenia, should show MMN alterations related with attention deficits. The aims of this work were to assess whether (1) MMN is altered in cirrhotic patients with MHE, compared to those without MHE, (2) MMN changes in parallel with performance in attention tests and/or MHE in a longitudinal study, and (3) MMN predicts performance in attention tests and/or in the Psychometric Hepatic Encephalopathy Score (PHES). We performed MMN analysis as well as attention and coordination tests in 34 control subjects and in 37 patients with liver cirrhosis without MHE and 23 with MHE. Patients with MHE show reduced performance in selective and sustained attention tests and in visuomotor and bimanual coordination tests. The MMN wave area was reduced in patients with MHE, but not in those without MHE. In the longitudinal study, MMN area improved in parallel with performance in attention tests and PHES in 4 patients and worsened in parallel in another 4. Logistic regression analyses showed that MMN area predicts performance in attention tests and in PHES, but not in other tests or critical flicker frequency. Receiver operating characteristic curve analyses showed that MMN area predicts attention deficits in the number connection tests A and B, Stroop tasks, and MHE, with sensitivities of 75%-90% and specificities of 76%-83%.
CONCLUSION: MMN area is useful to diagnose attention deficits and MHE in patients with liver cirrhosis.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 21953369     DOI: 10.1002/hep.24704

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Richard K Sterling; Arun J Sanyal; Muhammad Siddiqui; Scott Matherly; Velimir Luketic; R Todd Stravitz; Michael Fuchs; Leroy R Thacker; HoChong Gilles; Melanie B White; Ariel Unser; James Hovermale; Edith Gavis; Nicole A Noble; James B Wade
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-17       Impact factor: 11.382

3.  Current state of knowledge of hepatic encephalopathy (part II): changes in brain white matter tracts integrity are associated with cognitive deficits in minimal hepatic encephalopathy.

Authors:  Carmina Montoliu; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2016-09-20       Impact factor: 3.584

4.  Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats.

Authors:  Alba Gonzalez-Usano; Omar Cauli; Ana Agusti; Vicente Felipo
Journal:  ACS Chem Neurosci       Date:  2013-11-26       Impact factor: 4.418

5.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

Review 6.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

Review 7.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

8.  Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.

Authors:  Vicente Felipo; Amparo Urios; Carla Giménez-Garzó; Omar Cauli; Maria-Jesús Andrés-Costa; Olga González; Miguel A Serra; Javier Sánchez-González; Roberto Aliaga; Remedios Giner-Durán; Vicente Belloch; Carmina Montoliu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 9.  Hepatic encephalopathy: effects of liver failure on brain function.

Authors:  Vicente Felipo
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

10.  Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition.

Authors:  Ana Agusti; Jennifer L Dziedzic; Vicente Hernandez-Rabaza; Tomas R Guilarte; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2013-12-04       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.